HighBeam QuickSearch
Get direct access to articles and research when you
add HighBeam to your browser's search toolbar.
|
-
-
Pierre Fabre Dermo Cosmetique USA to Acquire Genesis Pharmaceutical, Inc.
-
PR Newswire; Oct 2, 2002; 700+ Words
...that it has acquired Genesis Pharmaceutical, Inc., and its subsidiary, C&M Pharmacal, Inc. The acquisition will allow...1-212-845-4264, d.venech@nrp-euro.com, for Genesis Pharmaceutical, Inc.
-
-
COPLEY PHARMACEUTICAL, INC. NAMES GABRIEL R. CIPAU, PH.D., PRESIDENT, CEO AND BOARD MEMBER;
-
PR Newswire; May 15, 1995; 700+ Words
Jane C.I. Hirsh, President...Pharmaceutical, Inc. (Nasdaq: CPLY...R. Cipau, Ph.D., as Copley's...announced that Jane C.I. Hirsh, Copley...s Board. Copley Pharmaceutical, Inc. is a leading manufacturer...over-the-counter pharmaceuticals in a variety of dosages...
-
-
DOV Pharmaceutical, Inc. Announces Successful Closing of Exchange Offer for 2.50% Convertible Subordinated Debentures Due 2025.
-
PR Newswire; Mar 15, 2007; 700+ Words
...FirstCall/ -- DOV Pharmaceutical, Inc. ("DOV" or the...784 shares of Series C Convertible Preferred...000 shares of Series D Convertible Preferred...Offer. The Series C and D Convertible...DOV Pharmaceutical, Inc., +1-732-907...
-
-
DOV Pharmaceutical, Inc. Announces Extension of Exchange Offer.
-
PR Newswire; Mar 6, 2007; 700+ Words
...FirstCall/ -- DOV Pharmaceutical, Inc. (Pink Sheets...shares of new series C convertible preferred...shares of new series D convertible preferred...some of the largest pharmaceutical markets in the world...Pharmaceutical, Inc., Investor Relations...
-
-
Glyko Biomedical Ltd. Announces Its 38%-Owned Affiliate, BioMarin Pharmaceutical, Inc., Raised $11.5 Million in Private Placements.
-
Business Wire; Aug 6, 1998; 700+ Words
...affiliate, BioMarin Pharmaceutical, Inc., a privately held...carbohydrate analysis tools for pharmaceutical and life sciences researchers...BioMarin Pharmaceutical, Inc. BioMarin is a privately...Biomedical Ltd. John C. Klock M.D., 415/382-3500...
-
-
"About" Doesn't Get Around Limitations Imposed By Intrinsic Evidence.(Ortho-McNeil Pharmaceutical Inc. v Caraco Pharmaceutical Laboratories Ltd.)
-
Mondaq Business Briefing; Mar 8, 2007; ; 700+ Words
...Ortho-McNeil Pharm. Inc. v. Caraco Pharm. Labs...2007) (McKinney, C.J. of S.D. Ind., by designation). Ortho-McNeil Pharmaceutical, Inc. owns a patent that relates...for related articles (c) Mondaq Ltd, 2007...
-
-
Glyko Biomedical Ltd. Announces its 36.2%-Owned Affiliate, BioMarin Pharmaceutical Inc., and Genzyme Form Joint Venture to Develop New Product to Treat Fatal Genetic Disease.
-
Business Wire; Sep 15, 1998; 700+ Words
...owned affiliate, BioMarin Pharmaceutical Inc., a privately held biopharmaceutical...Calif. Emil Kakkis, M.D., Ph.D., president of BioMarin...Elizabeth F. Neufeld, Ph.D., professor and chair...Glyko Biomedical Ltd. John C. Klock MD, 415/382...
-
-
Schein Pharmaceutical Inc. Sued for Federal Securities Law Violations, Announces Berger & Montague, P.C.
-
Business Wire; Sep 15, 1998; 700+ Words
...alleges that Schein Pharmaceutical Inc. (NYSE: SHP) and...Steris Laboratories, Inc. plant in Phoenix...amp; Montague, P.C. The law firm of...against Waste Management Inc., Sunbeam Corp...Esq., or Genna D. Kidd, Esq., Berger...
-
-
DOV Pharmaceutical, Inc. Announces First Quarter 2007 Results.
-
PR Newswire; May 14, 2007; 700+ Words
...PRNewswire-FirstCall/ -- DOV Pharmaceutical, Inc. ("DOV" or the "Company...for 439,784 shares of series C and 100,000 shares of series D convertible preferred stock...the 439,784 shares of series C convertible preferred stock...
-
-
Berger & Montague, P.C. Files Securities Class Action Against Schein Pharmaceutical, Inc. (NYSE: SHP).
-
PR Newswire; Sep 18, 1998; 700+ Words
...PRNewswire/ -- Schein Pharmaceutical, Inc. (NYSE: SHP) and...amp; Montague, P.C. The case is filed...Steris Laboratories, Inc. plant. Following...amp; Montague, P.C. The law firm of...Esq., or Genna D. Kidd, Esq., Berger...
-
-
Cohen, Milstein, Hausfeld & Toll, P.L.L.C. Announces Lawsuit Filed Against Dov Pharmaceutical, Inc. and Certain of Its Officers and Directors and Lead Underwriters On Behalf of Investors.
-
Business Wire; May 19, 2002; 700+ Words
...amp; Toll, P.L.L.C., on behalf of its client...filed a lawsuit against Dov Pharmaceutical, Inc. (NASDAQ: DOVP) in the...amp; Toll, P.L.L.C. - has significant experience...offices in Washington, D.C., Seattle, and New York...
-
-
Cohen, Milstein, Hausfeld & Toll, P.L.L.C. Announces Lawsuit Filed Against Dov Pharmaceutical, Inc. ("Dov") (Nasdaq: DOVP) and Certain of Its Officers And Directors and Lead Underwriters on Behalf of Investors.
-
PR Newswire; May 1, 2002; 700+ Words
...amp; Toll, P.L.L.C., on behalf of its client...filed a lawsuit against Dov Pharmaceutical, Inc. in the United States District...amp; Toll, P.L.L.C. -- has significant experience...offices in Washington, D.C., Seattle, and New York...
-
-
Weiss & Yourman Law Office Announces Class Action Lawsuit Against DOV Pharmaceutical, Inc.
-
Business Wire; May 24, 2002; 700+ Words
...May 24, 2002 A class action lawsuit against DOV Pharmaceutical, Inc. ("DOV" or the "Company")(NASDAQ:DOVP...you wish to provide to us, please contact: David C. Katz, Mark D. Smilow, and/or James E. Tullman, (888) 593...
-
-
Performers.coms "Penny Stocks that Perform" for this morning are; Pipex Pharmaceuticals, Inc. (OTCBB: PPXP), Drinks Americas, Inc. (Pink sheets & OTCBB: DKAM), Coastal Technologies, Inc. (Pink Sheets:CTTJ), Pricester.com, Inc. (OTCBB: PRCC), Ecoloclean Industries,...
-
M2 Presswire; Apr 18, 2007; 700+ Words
...are; Pipex Pharmaceuticals, Inc. (OTCBB...GTHA)(C)1994...Pipex Pharmaceuticals, Inc...Pipex Pharmaceuticals, Inc., a specialty pharmaceutical company developing...R&D and Clinical...A Pfizer Inc. Company...
-
-
Solvay Pharmaceuticals, Inc. Announces Retirement of CEO Laurence Downey and Appointment of Stephen Hill as New President and Chief Executive Officer.
-
Business Wire; Jan 30, 2008; 700+ Words
...Pharmaceuticals, Inc. announced today...J. Downey, M.D., has elected to...M.A., F.R.C.S, as its new...Pharmaceuticals, Inc. on April 1, 2008...Cautreels, Ph.D., Global CEO of...offer to join Solvay Pharmaceuticals. We have worked...experience in the ...
-
-
Savient Pharmaceuticals, Inc. Submits New Drug Application for Soltamox to the U.S. Food and Drug Administration.
-
Business Wire; Jan 6, 2005; 700+ Words
...emerging specialty pharmaceutical company engaged...and marketing pharmaceutical products that...Rosemont Pharmaceuticals Ltd. located...with O.R.C.H.A.PHARM...Rosemont Pharmaceuticals recently completed...oral liquids pharmaceutical business model...Pharmaceuticals, ...
-
-
Savient Pharmaceuticals, Inc. Announces an Exclusive Marketing Collaboration in Germany for Soltamox for the Treatment of Hormonally Sensitive Breast Cancer.
-
Business Wire; Jan 6, 2005; 700+ Words
...Pharmaceuticals Rosemont Pharmaceuticals is the leading developer...PHARM GmbH O.R.C.A.PHARM is a...independent German pharmaceutical company. Since...in 1999, O.R.C.A.PHARM has...leading provider of pharmaceuticals, medical products...Pharmaceuticals, Inc. Savient ...
-
-
Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data at Society Of Nuclear Medicine 2007 Annual Meeting.
-
Business Wire; Jun 4, 2007; 700+ Words
...Molecular Insight Pharmaceuticals, Inc. (NASDAQ...Washington, D.C. The presentations...molecular imaging pharmaceutical for imaging...molecular imaging pharmaceutical, MIP-1072...Mok1, D. H. Hunter2, C. Bensimon4...Molecular Insight Pharmaceuticals, Inc., ...
-
-
Cortex Pharmaceuticals Inc., Schizophrenia Drugs Reviewed.
-
M2 Presswire; Mar 8, 2007; 700+ Words
...Cortex Pharmaceuticals Inc., Schizophrenia Drugs Reviewed(C)1994-2007 M2...Cortex Pharmaceuticals Inc. (COR) were up...privately held Xytis Pharmaceuticals. About NeuroInvestment...oriented R&D programs organized...for large and small pharmaceutical firms. NI ...
-
-
China Yongxin Pharmaceuticals Inc. Finalizes Restructuring and Obtains New Ticker Symbol.
-
M2 Presswire; May 22, 2008; 700+ Words
...2008-InvestSource Inc.: China Yongxin Pharmaceuticals Inc. Finalizes Restructuring...New Ticker Symbol(C)1994-2008 M2 COMMUNICATIONS...news: China Yongxin Pharmaceuticals Inc. (OTCBB:CYXN), Teva Pharmaceutical Industries Ltd...
|
|